A strong performance by the Health Care Systems business of Varian Associates helped buoy the Palo Alto, CA, company's financial results for the fourth quarter (end-September). Varian reported that its Health Care business turned in a fourth-quarter
A strong performance by the Health Care Systems business of Varian Associates helped buoy the Palo Alto, CA, company's financial results for the fourth quarter (end-September). Varian reported that its Health Care business turned in a fourth-quarter surge of sales that helped offset weakness experienced earlier this year.
Varian chairman and chief executive Tracy O'Rourke said that the Health Care business turned in the sharpest improvement among Varian's three main businesses, which include instruments and semiconductor equipment. Fourth-quarter sales for the unit were $158 million, rising 40% over the third quarter of 1997. O'Rourke attributed the improvement to acceptance of new cancer-care products from its oncology systems operation, as well as international sales.
For the entire company in the fourth quarter, Varian registered revenues of $405.8 million, down 2% compared with $413.4 million in the fourth quarter of fiscal 1996. The company's net income was $33 million, including a one-time gain from the sale of a business unit, compared with net income of $29.1 million in the fourth quarter of 1996.
For the year, Varian's revenues were $1.426 billion, down 11% compared with revenues of $1.599 billion in fiscal 1996. The company's net income was $115.6 million, compared with $122.1 million the prior year. Despite the lower revenues and net income, Varian said that all three of its businesses bounced back in the fourth quarter and should turn in strong performances in 1998.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.